2025
SJR Q1
JCR Q1 · 5,2
62 matched articles
SCIE
Journal detail
Toxicology
- Publisher
- Elsevier Ireland Ltd
- Country
- Ireland · Western Europe
- Type
- journal
- ISSN
-
0300483X18793185
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,267
- Quartile Q1
- H-Index 189
- Cites/doc 5,41
- Docs (3y) 639
- Cites (3y) 3.931
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,2
- 5Y JIF 5,5
- JCI 1,38
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Toxicology Q1
Areas
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy | Toxicology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,267 | 5,2 | 5,5 | 1,38 | Q1 | 189 |
| 2024 | Q1 | Q1 | 1,106 | 4,6 | 4,8 | 1,31 | Q1 | 182 |
| 2023 | Q1 | Q1 | 1,014 | 4,8 | 4,4 | 1,27 | Q1 | 182 |
| 2022 | Q1 | Q1 | 0,844 | 4,5 | 4,6 | 1,16 | Q1 | 182 |
| 2021 | Q2 | Q1 | 0,778 | 4,6 | 4,8 | 1,09 | Q1 | 182 |
| 2020 | Q1 | Q2 | 1,067 | 4,2 | 4,7 | 1,28 | Q1 | 182 |
| 2019 | Q1 | Q1 | 1,029 | 4,1 | 3,9 | 1,24 | Q1 | 182 |
| 2018 | — | Q1 | — | 3,5 | 3,8 | 1,29 | Q1 | — |
| 2017 | Q1 | Q2 | 1,1 | 3,3 | 3,6 | 1,19 | Q1 | 182 |
| 2016 | Q1 | Q1 | 1,468 | 3,6 | 3,9 | — | — | 182 |
| 2015 | Q1 | Q1 | 1,345 | 3,8 | 4 | — | — | 182 |
| 2014 | Q1 | Q1 | 1,23 | 3,6 | 3,8 | — | — | 182 |
| 2013 | Q1 | Q1 | 1,239 | 3,7 | 3,9 | — | — | 182 |
| 2012 | Q1 | Q1 | 1,303 | 4 | 3,8 | — | — | 182 |
| 2011 | Q1 | Q1 | 1,273 | 3,7 | 3,5 | — | — | 182 |
| 2010 | Q1 | Q1 | 1,218 | 3,6 | 3,4 | — | — | 182 |
| 2009 | — | Q1 | — | 3,2 | 3,3 | — | — | — |
| 2008 | — | Q2 | — | 2,8 | 3,1 | — | — | — |
| 2007 | — | Q1 | — | 2,9 | 3 | — | — | — |
| 2006 | — | Q1 | — | 2,7 | — | — | — | — |
| 2005 | — | Q1 | — | 2,6 | — | — | — | — |
| 2004 | — | Q1 | — | 2,7 | — | — | — | — |
| 2003 | — | Q1 | — | 2,1 | — | — | — | — |
| 2002 | — | Q1 | — | 2,5 | — | — | — | — |
| 2001 | — | Q2 | — | 1,8 | — | — | — | — |
| 2000 | — | Q2 | — | 1,4 | — | — | — | — |
| 1999 | — | Q2 | — | 1,3 | — | — | — | — |
| 1998 | — | Q2 | — | 1,4 | — | — | — | — |
| 1997 | — | Q2 | — | 1,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 62/356 |
| 2025 | TOXICOLOGY | SCIE | Q1 | Q1 | 16/106 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 57/352 |
| 2024 | TOXICOLOGY | SCIE | Q1 | Q1 | 15/106 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 50/354 |
| 2023 | TOXICOLOGY | SCIE | Q1 | Q1 | 14/106 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 76/278 |
| 2022 | TOXICOLOGY | SCIE | Q1 | Q1 | 16/94 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 92/279 |
| 2021 | TOXICOLOGY | SCIE | Q1 | Q1 | 22/94 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 95/276 |
| 2020 | TOXICOLOGY | SCIE | Q2 | Q1 | 28/93 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 57/271 |
| 2019 | TOXICOLOGY | SCIE | Q1 | Q1 | 15/92 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 69/267 |
| 2018 | TOXICOLOGY | SCIE | Q1 | Q1 | 23/93 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 76/261 |
| 2017 | TOXICOLOGY | SCIE | Q2 | Q1 | 26/94 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 58/257 |
| 2016 | TOXICOLOGY | SCIE | Q1 | — | 21/92 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 51/255 |
| 2015 | TOXICOLOGY | SCIE | Q1 | — | 13/90 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 58/255 |
| 2014 | TOXICOLOGY | SCIE | Q1 | — | 16/88 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 48/256 |
| 2013 | TOXICOLOGY | SCIE | Q1 | — | 14/87 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 43/261 |
| 2012 | TOXICOLOGY | SCIE | Q1 | — | 11/85 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 52/261 |
| 2011 | TOXICOLOGY | SCIE | Q1 | — | 16/83 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 54/252 |
| 2010 | TOXICOLOGY | SCIE | Q1 | — | 15/83 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 67/237 |
| 2009 | TOXICOLOGY | SCIE | Q1 | — | 19/77 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 73/219 |
| 2008 | TOXICOLOGY | SCIE | Q2 | — | 20/75 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 63/205 |
| 2007 | TOXICOLOGY | SCIE | Q1 | — | 15/73 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 66/199 |
| 2006 | TOXICOLOGY | SCIE | Q1 | — | 15/76 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 58/193 |
| 2005 | TOXICOLOGY | SCIE | Q1 | — | 13/75 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 51/187 |
| 2004 | TOXICOLOGY | SCIE | Q1 | — | 12/75 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 69/185 |
| 2003 | TOXICOLOGY | SCIE | Q1 | — | 17/77 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 49/188 |
| 2002 | TOXICOLOGY | SCIE | Q1 | — | 12/76 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 65/186 |
| 2001 | TOXICOLOGY | SCIE | Q2 | — | 21/78 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 83/181 |
| 2000 | TOXICOLOGY | SCIE | Q2 | — | 32/77 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 77/175 |
| 1999 | TOXICOLOGY | SCIE | Q2 | — | 28/74 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 71/178 |
| 1998 | TOXICOLOGY | SCIE | Q2 | — | 23/71 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 69/157 |
| 1997 | TOXICOLOGY | SCIE | Q2 | — | 20/63 |